Qidong You Selected Research

Annexin A5

3/2014	Synthesis and biological evaluation of baicalein derivatives as potent antitumor agents.
11/2008	Gambogic acid induced tumor cell apoptosis by T lymphocyte activation in H22 transplanted mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qidong You Research Topics

Disease

82	Neoplasms (Cancer) 03/2024 - 08/2006
17	Breast Neoplasms (Breast Cancer) 11/2019 - 01/2009
9	Hypoxia (Hypoxemia) 03/2023 - 07/2015
9	Hepatocellular Carcinoma (Hepatoma) 08/2013 - 08/2006
7	Inflammation (Inflammations) 01/2024 - 05/2009
5	Neoplasm Metastasis (Metastasis) 04/2017 - 01/2009
4	Cardiac Arrhythmias (Arrythmia) 12/2022 - 04/2007
4	Anemia 10/2020 - 01/2017
4	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 06/2011
3	Atrial Fibrillation 12/2022 - 09/2008
3	Leukemia 01/2021 - 11/2016
3	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2020 - 02/2018
3	Carcinoma (Carcinomatosis) 06/2015 - 11/2012
2	Colitis 05/2023 - 02/2016
2	Prostatic Neoplasms (Prostate Cancer) 10/2019 - 01/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2018 - 09/2017
2	Glioma (Gliomas) 11/2015 - 10/2013
1	Infections 01/2024
1	Demyelinating Diseases (Demyelinating Disease) 12/2023
1	Alzheimer Disease (Alzheimer's Disease) 12/2023
1	Neuroinflammatory Diseases 01/2023
1	Hypersensitivity (Allergy) 01/2023
1	Neuralgia (Stump Neuralgia) 01/2023
1	Pain (Aches) 01/2023
1	Rare Diseases (Rare Disease) 12/2022
1	Lung Neoplasms (Lung Cancer) 09/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/2021

Drug/Important Bio-Agent (IBA)

16	wogoninIBA 11/2019 - 08/2006
14	Proteins (Proteins, Gene)FDA Link 02/2024 - 10/2008
12	gambogic acidIBA 04/2017 - 10/2008
10	FlavonoidsIBA 11/2016 - 05/2009
8	5,7- dihydroxy- 6- methoxy- 2- phenylchromen- 4- oneIBA 11/2015 - 01/2009
6	Messenger RNA (mRNA)IBA 02/2024 - 12/2011
6	EnzymesIBA 03/2019 - 09/2013
6	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2019 - 05/2014
5	Transcription Factors (Transcription Factor)IBA 11/2023 - 01/2017
5	Phosphotransferases (Kinase)IBA 01/2022 - 10/2013
5	Tamoxifen FDA LinkGeneric 01/2019 - 09/2009
5	Selective Estrogen Receptor Modulators (SERM)IBA 01/2019 - 09/2009
4	Therapeutic UsesIBA 12/2023 - 01/2009
4	ProdrugsIBA 03/2023 - 10/2017
4	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 05/2020 - 12/2015
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 06/2009
4	Estrogen ReceptorsIBA 01/2018 - 05/2014
4	CateninsIBA 11/2016 - 10/2013
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2024 - 01/2020
3	Kv1.5 Potassium ChannelIBA 12/2022 - 09/2008
3	Cisplatin (Platino)FDA LinkGeneric 10/2020 - 10/2017
3	Prolyl-Hydroxylase InhibitorsIBA 10/2020 - 01/2017
3	XanthonesIBA 10/2017 - 04/2011
3	PiperazineIBA 01/2014 - 01/2009
3	Potassium Channels (Potassium Channel)IBA 01/2014 - 04/2007
3	xanthoneIBA 11/2012 - 12/2011
2	Carrier Proteins (Binding Protein)IBA 02/2024 - 01/2023
2	Peptides (Polypeptides)IBA 01/2024 - 09/2021
2	Molecular Chaperones (Chaperone, Molecular)IBA 01/2024 - 01/2022
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 12/2023 - 01/2021
2	Hormones (Hormone)IBA 01/2022 - 09/2009
2	Protein Kinases (Protein Kinase)IBA 01/2022 - 01/2014
2	Adenosine Triphosphatases (ATPase)IBA 10/2021 - 01/2021
2	Erythropoietin FDA Link 10/2020 - 01/2017
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2019 - 04/2011
2	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 08/2006
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2018 - 10/2017
2	NAD (NADH)IBA 12/2018 - 01/2018
2	Oxidoreductases (Dehydrogenase)IBA 12/2018 - 01/2018
2	quinone (benzoquinone)IBA 12/2018 - 01/2018
2	LigandsIBA 04/2018 - 11/2017
2	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 01/2017
2	Raloxifene Hydrochloride (Evista)FDA Link 01/2018 - 09/2009
2	Dihydrotestosterone (Androstanolone)IBA 01/2017 - 01/2014
2	wogonosideIBA 11/2016 - 05/2009
2	beta-lapachoneIBA 03/2016 - 07/2014
2	Annexin A5IBA 03/2014 - 11/2008
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 05/2013 - 01/2009
2	LYG 202IBA 06/2011 - 01/2010
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 02/2024
1	Insulin-Like PeptidesIBA 02/2024
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 12/2023
1	Dextran SulfateIBA 05/2023
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 05/2023
1	CytokinesIBA 01/2023
1	6-methyladenineIBA 01/2023
1	tissue-factor-pathway inhibitor 2 (PP5)IBA 01/2023
1	benzocycloheptapyridineIBA 01/2023
1	Oncogene Proteins (Oncogene Protein)IBA 01/2022
1	RibonucleoproteinsIBA 01/2022
1	SteroidsIBA 01/2022
1	HydrocarbonsIBA 09/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2021
1	Methylcellulose (BFL)IBA 08/2021
1	venetoclaxIBA 08/2021
1	MethyltransferasesIBA 01/2021
1	Threonine (L-Threonine)FDA Link 01/2021
1	Serine (L-Serine)FDA Link 01/2021
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2021

Therapy/Procedure

25	Therapeutics 01/2024 - 05/2008
2	Oral Administration 01/2021 - 10/2020
2	Intravenous Injections 07/2011 - 03/2009
1	Immunotherapy 03/2024